Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2023-01-18 00:00:00 ET · period of report 2023-01-16 · accession 0001104659-23-004721 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-18 | 2022-05-04+ | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -6,116 | 581.0K | -1% | $0 |
| D | 2023-01-18 | 2023-01-16 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir | A - Grant | $0.00 | +600.0K | 600.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-28 | G | D | 3,116 | $0.00 | 598,096 | D | — | — | (F1) Includes an aggregate of 164 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2022. |
| 2 | Common | Common Stock | 2022-05-04 | G | D | 3,000 | $0.00 | 581,048 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-01-16 | A | A | 600,000 | $0.00 | 600,000 | D | $12.17 · — to 2033-01-15 | 600,000 Common Stock | (F2) The stock option vests in 48 equal monthly installments following the date of grant. |